Wellington Management Group’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.82M Sell
41,796
-5,085
-11% -$308K ﹤0.01% 1556
2026
Q1
$2.6M Sell
46,881
-14,306
-23% -$770K ﹤0.01% 1509
2025
Q4
$2.97M Sell
61,187
-5,544
-8% -$216K ﹤0.01% 1512
2025
Q3
$2.04M Sell
66,731
-13,482
-17% -$309K ﹤0.01% 1623
2025
Q2
$1.78M Buy
80,213
+4,192
+6% +$87.7K ﹤0.01% 1605
2025
Q1
$1.41M Buy
76,021
+9,554
+14% +$159K ﹤0.01% 1630
2024
Q4
$880K Buy
66,467
+528
+0.8% +$12.8K ﹤0.01% 1739
2024
Q3
$2.21M Buy
65,939
+3,048
+5% +$104K ﹤0.01% 1521
2024
Q2
$1.58M Buy
62,891
+3,843
+7% +$89.5K ﹤0.01% 1570
2024
Q1
$1.33M Buy
+59,048
New +$1.4M ﹤0.01% 1620
2023
Q1
Sell
-15,183
Closed -$471K 1990
2022
Q4
$471K Sell
15,183
-651
-4% -$18.4K ﹤0.01% 1814
2022
Q3
$404K Sell
15,834
-857
-5% -$20.1K ﹤0.01% 1842
2022
Q2
$339K Hold
16,691
﹤0.01% 1930
2022
Q1
$413K Buy
+16,691
New +$505K ﹤0.01% 1951
2019
Q4
Sell
-6,830
Closed -$239K 2008
2019
Q3
$239K Sell
6,830
-2,243
-25% -$107K ﹤0.01% 1973
2019
Q2
$512K Buy
+9,073
New +$653K ﹤0.01% 1904
2018
Q2
Sell
-8,930
Closed -$929K 2222
2018
Q1
$929K Buy
+8,930
New +$1.01M ﹤0.01% 1910

Other funds holding ANAB

Wellington Management Group's ANAB Position: Q2 2026 in Review

Wellington Management Group reduced its AnaptysBio (ANAB) stake by 11% in Q2 2026, selling an estimated $308K and leaving 41,796 shares worth $2.82M. The position accounts for ﹤0.01% of the portfolio, ranked #1556.

Wellington Management Group first reported a position in ANAB in Q1 2018 and has held it in 17 quarters since. The position peaked at $2.97M in Q4 2025. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Wellington Management Group held 41,796 shares of AnaptysBio worth $2.82M as of Q2 2026.
  • Wellington Management Group sold 5,085 AnaptysBio shares in Q2 2026, an estimated $308K.
  • AnaptysBio made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1556 holding.
  • Wellington Management Group first reported a position in AnaptysBio in Q1 2018 and has held it in 17 quarters since.
  • Wellington Management Group's AnaptysBio position peaked at $2.97M in Q4 2025.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.